Wellington Shields Capital Management’s Exact Sciences EXAS Stock Holding History

Wellington Shields Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,300	Closed	-$244K	–	307
2023 Q4	$244K	Sell	3,300 -1,700	-34%	-$111K	0.03%	212
2023 Q3	$341K	Sell	5,000 -2,500	-33%	-$212K	0.05%	183
2023 Q2	$704K	Buy	7,500 +500	+7%	+$39K	0.09%	127
2023 Q1	$475K	Buy	7,000 +500	+8%	+$32.1K	0.06%	149
2022 Q4	$322K	Buy	+6,500	New	+$266K	0.04%	185
2022 Q2	–	Sell	-3,000	Closed	-$210K	–	306
2022 Q1	$210K	Hold	3,000	–	–	0.02%	247
2021 Q4	$233K	Hold	3,000	–	–	0.03%	268
2021 Q3	$286K	Hold	3,000	–	–	0.04%	229
2021 Q2	$373K	Hold	3,000	–	–	0.05%	230
2021 Q1	$395K	Buy	+3,000	New	+$411K	0.04%	224

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Shields Capital Management's EXAS Position: Q1 2024 in Review

Wellington Shields Capital Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,300 shares — an estimated $244K sold.

Wellington Shields Capital Management first reported a position in EXAS in Q1 2021 and held it in 10 quarters. The position peaked at $704K in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

Wellington Shields Capital Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
Wellington Shields Capital Management sold 3,300 Exact Sciences shares in Q1 2024, an estimated $244K.
Wellington Shields Capital Management first reported a position in Exact Sciences in Q1 2021 and held it in 10 quarters.
Wellington Shields Capital Management's Exact Sciences position peaked at $704K in Q2 2023.
627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Wellington Shields Capital Management's 13F filing for Q1 2024, filed 3 May 2024.